Senior Manager, SEC Reporting @ PRE-IPO NETWORK COMPANY (aiming to go IPO through SPAC by filing S-4) (April 2021 - February 2022)
Associated Director, Financial Reporting @ (August 2013 - March 2021)
Senior SEC Reporting and Finance Manager @ MAP Pharmaceuticals (acquired by Allergan Inc. in 2013) (December 2008 - July 2013)
External Reporting Manager @ (December 2005 - November 2008)
Senior External Reporting Analyst @ Nuance Communications (acquired by Scansoft Inc. in 2005) (October 2002 - December 2005)
Financial Reporting Analyst - level II @ (March 2001 - October 2002)
Mei Wang Education
Guangzhou University of Foreign Languages and Foreign Trade
Concordia University, John Molson School of Business
Univ Of Nc Hosps, Internal Medicine
Mei Wang Skills
Reporting
Securities and Exchange Commission
Finance
Mei Wang Summary
Mei Wang, based in Cupertino, CA, US, is currently a Director, SEC Reporting and Technical Accounting at CytomX Therapeutics. Mei Wang brings experience from previous roles at PRE-IPO NETWORK COMPANY (aiming to go IPO through SPAC by filing S-4), Pacific Biosciences, MAP Pharmaceuticals (acquired by Allergan Inc. in 2013) and Blue Coat Systems acquired by Symantec. Mei Wang holds a Guangzhou University of Foreign Languages and Foreign Trade. With a robust skill set that includes Reporting, Securities and Exchange Commission, Finance and more. Mei Wang has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mei Wang?
Find contact details for 700 million professionals.